<DOC>
	<DOC>NCT00171509</DOC>
	<brief_summary>The purpose of this study is to determine whether cyclosporine microemulsion given once a day instead of twice a day benefits kidney function, blood pressure, lipid profile and glucose control in stable liver transplant recipients. The study also aims to identify the target ranges of levels of cyclosporine microemulsion in the blood.</brief_summary>
	<brief_title>Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>At least 6 months posttransplant At least one of the following: stable or deteriorating kidney function, high blood pressure, high lipids, high glucose Receiving stable doses of cyclosporine microemulsion for the past 3 months Severe rejection within the past 3 months Severe kidney dysfunction Transplanted for hepatitis C or autoimmune hepatitis Other protocoldefined exclusion criteria applied</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Liver transplant, adults, once a day administration, Immunosuppressants</keyword>
</DOC>